Short Interest in Axon Enterprise, Inc. (NASDAQ:AXON) Decreases By 17.8%

Axon Enterprise, Inc. (NASDAQ:AXON) was the recipient of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 1,570,000 shares, a decrease of 17.8% from the March 15th total of 1,910,000 shares. Approximately 2.2% of the company’s stock are short sold. Based on an average daily volume of 833,100 shares, the short-interest ratio is currently 1.9 days.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on AXON shares. The Goldman Sachs Group upped their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Barclays restated a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Northcoast Research lowered Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Finally, TD Cowen initiated coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, two have given a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $626.45.

Axon Enterprise Stock Performance

AXON traded down $26.26 during trading hours on Monday, hitting $533.27. The company’s stock had a trading volume of 233,232 shares, compared to its average volume of 788,935. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise has a fifty-two week low of $273.52 and a fifty-two week high of $715.99. The company has a 50-day simple moving average of $556.27 and a 200 day simple moving average of $567.52. The firm has a market capitalization of $40.86 billion, a PE ratio of 137.80, a PEG ratio of 5.17 and a beta of 1.13.

Insider Activity at Axon Enterprise

In other news, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares of the company’s stock, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 6.10% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Axon Enterprise

Several institutional investors have recently bought and sold shares of AXON. Capital World Investors lifted its position in Axon Enterprise by 86.4% in the fourth quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company’s stock worth $1,079,145,000 after purchasing an additional 841,772 shares during the period. Alliancebernstein L.P. raised its stake in shares of Axon Enterprise by 273.8% in the 4th quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company’s stock worth $659,128,000 after buying an additional 812,337 shares in the last quarter. Norges Bank acquired a new stake in shares of Axon Enterprise in the fourth quarter valued at $482,081,000. GQG Partners LLC acquired a new position in Axon Enterprise during the fourth quarter worth about $478,349,000. Finally, GAMMA Investing LLC raised its position in Axon Enterprise by 58,725.5% in the first quarter. GAMMA Investing LLC now owns 764,731 shares of the biotechnology company’s stock worth $402,210,000 after acquiring an additional 763,431 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.